Oxidative mitochondrial DNA damage in peripheral blood mononuclear cells is associated with reduced volumes of hippocampus and subcortical gray matter in chronically HIV-infected patients.

[1]  K. Lee,et al.  NLRP3 inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation , 2014, Cell Death and Disease.

[2]  Fair M. Vassoler,et al.  Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system , 2014, Journal of NeuroVirology.

[3]  Gregory R. Kirk,et al.  Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter , 2013, Neurology.

[4]  F. Blanco,et al.  Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes. , 2012, Arthritis and rheumatism.

[5]  Gregory R. Kirk,et al.  Regional cortical thinning associated with detectable levels of HIV DNA. , 2012, Cerebral cortex.

[6]  M. Budoff,et al.  Vitamin D levels and markers of arterial dysfunction in HIV. , 2012, AIDS research and human retroviruses.

[7]  E. Gozal,et al.  Aerobic Production and Utilization of Lactate Satisfy Increased Energy Demands Upon Neuronal Activation in Hippocampal Slices and Provide Neuroprotection Against Oxidative Stress , 2012, Front. Pharmacol..

[8]  Susan Morgello,et al.  CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy , 2011, AIDS.

[9]  Jianhui Zhong,et al.  Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment , 2011, AIDS.

[10]  Markus Schuelke,et al.  Gamma oscillations in the hippocampus require high complex I gene expression and strong functional performance of mitochondria. , 2011, Brain : a journal of neurology.

[11]  Paul M. Thompson,et al.  Subcortical brain atrophy persists even in HAART-regulated HIV disease , 2011, Brain Imaging and Behavior.

[12]  Michael J. Taylor,et al.  Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era , 2010, Journal of NeuroVirology.

[13]  D. Wallace,et al.  Mitochondrial energetics and therapeutics. , 2010, Annual review of pathology.

[14]  D. Kvale,et al.  Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms? , 2009, The Journal of antimicrobial chemotherapy.

[15]  A. Kurosky,et al.  Mitochondrial Dysfunction Increases Allergic Airway Inflammation1 , 2009, The Journal of Immunology.

[16]  A. Valavanidis,et al.  8-hydroxy-2′ -deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis , 2009, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[17]  M. Gerschenson,et al.  Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen. , 2009, The Journal of antimicrobial chemotherapy.

[18]  M. Michaelis,et al.  Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress , 2009, BMC Neuroscience.

[19]  Dianne Langford,et al.  HIV and antiretroviral therapy in the brain: neuronal injury and repair , 2008, Nature Reviews Neuroscience.

[20]  D. Fuchs,et al.  Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. , 2007, The Journal of infectious diseases.

[21]  György Buzsáki,et al.  Gamma oscillations dynamically couple hippocampal CA3 and CA1 regions during memory task performance , 2007, Proceedings of the National Academy of Sciences.

[22]  J. Capeau,et al.  Some HIV Antiretrovirals Increase Oxidative Stress and Alter Chemokine, Cytokine or Adiponectin Production in Human Adipocytes and Macrophages , 2007, Antiviral therapy.

[23]  Xue-wen Chen,et al.  High intrinsic oxidative stress may underlie selective vulnerability of the hippocampal CA1 region. , 2005, Brain research. Molecular brain research.

[24]  Kiralee M. Hayashi,et al.  Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Simmonds,et al.  Influence of HAART on HIV-related CNS disease and neuroinflammation. , 2005, Journal of neuropathology and experimental neurology.

[26]  P. Reiss,et al.  Infection with HIV-1 induces a decrease in mtDNA. , 2005, The Journal of infectious diseases.

[27]  M. Kaul,et al.  HIV-1 infection and AIDS: consequences for the central nervous system , 2005, Cell Death and Differentiation.

[28]  Abraham Z. Snyder,et al.  A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume , 2004, NeuroImage.

[29]  Ò. Miró,et al.  Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  A. Barrier,et al.  Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients , 2004, Laboratory Investigation.

[31]  A. M. Dale,et al.  A hybrid approach to the skull stripping problem in MRI , 2004, NeuroImage.

[32]  J. Andersen,et al.  Oxidative stress in neurodegeneration: cause or consequence? , 2004, Nature Reviews Neuroscience.

[33]  J. Morrow,et al.  Oxidant stress is increased during treatment of human immunodeficiency virus infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  Y. Higuchi.  Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress. , 2003, Biochemical pharmacology.

[35]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[36]  T. Miura,et al.  Depletion of mitochondrial DNA in HIV‐1‐infected patients and its amelioration by antiretroviral therapy , 2003, Journal of medical virology.

[37]  J. Bell,et al.  Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat , 2003, Neuroscience.

[38]  G. Martínez,et al.  Contribution to characterization of oxidative stress in HIV/AIDS patients. , 2003, Pharmacological research.

[39]  V. Soriano,et al.  First-Line Therapy and Mitochondrial Damage: Different Nucleosides, Different Findings , 2003, HIV clinical trials.

[40]  Roger E Bumgarner,et al.  Cellular Gene Expression upon Human Immunodeficiency Virus Type 1 Infection of CD4+-T-Cell Lines , 2003, Journal of Virology.

[41]  L. Deecke,et al.  Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients , 2002, Neurology.

[42]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[43]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[44]  C. Hoppel,et al.  Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure. , 2001, Journal of molecular and cellular cardiology.

[45]  Stuart A. Lipton,et al.  Pathways to neuronal injury and apoptosis in HIV-associated dementia , 2001, Nature.

[46]  R. O’Reilly,et al.  Conjunctive representations in learning and memory: principles of cortical and hippocampal function. , 2001, Psychological review.

[47]  S. Biagioni,et al.  Neuronal glycolytic pathway impairment induced by HIV envenlope glyocprotein gp120 , 2000, Molecular and Cellular Biochemistry.

[48]  R. Tanzi,et al.  Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands , 2000, Nature Medicine.

[49]  Jean-Philippe Galons,et al.  Quantitative Volumetric Analyses of Brain Magnetic Resonance Imaging from Rat with Chronic Neuroinflammation , 2000, Experimental Neurology.

[50]  H. Gendelman,et al.  Mononuclear phagocytes mediate blood‐brain barrier compromise and neuronal injury during HIV‐1‐associated dementia , 2000, Journal of leukocyte biology.

[51]  V. Lévy,et al.  Neuronal apoptosis in human immunodeficiency virus infection. , 2000, Journal of neurovirology.

[52]  D. Wallace,et al.  Mitochondrial defects in cardiomyopathy and neuromuscular disease. , 2000, American heart journal.

[53]  S. Gartner.  HIV Infection and Dementia , 2000, Science.

[54]  P. Mcgeer,et al.  Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells , 2000, Journal of leukocyte biology.

[55]  L. Stivala,et al.  Zidovudine-induced experimental myopathy: dual mechanism of mitochondrial damage , 1999, Journal of the Neurological Sciences.

[56]  G. Wenk,et al.  The effects of a novel NSAID on chronic neuroinflammation are age dependent☆ , 1999, Neurobiology of Aging.

[57]  Chrétien,et al.  Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage , 1999, Neuropathology and applied neurobiology.

[58]  A. Dale,et al.  Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.

[59]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[60]  G. Wenk,et al.  Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS , 1999, Brain Research.

[61]  M. Mattson,et al.  HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative Stress , 1998, Experimental Neurology.

[62]  R. Miller,et al.  Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Beijnen,et al.  Antiretroviral drugs and the central nervous system. , 1998, AIDS.

[64]  J. Smeitink,et al.  Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway , 1998, AIDS.

[65]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[66]  P. Dobrzanski,et al.  Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease , 1998, Brain Research.

[67]  W. Griffin,et al.  Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression , 1998, Brain pathology.

[68]  Robert H. Brown,et al.  Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis , 1997, Journal of neurochemistry.

[69]  F. Iannotti,et al.  Differential Vulnerability of the CA1 and CA3 Subfields of the Hippocampus to Superoxide and Hydroxyl Radicals In Vitro , 1997, Journal of neurochemistry.

[70]  B. Van Houten,et al.  Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[71]  C. Olanow,et al.  Oxidative stress and the pathogenesis of Parkinson's disease , 1996, Neurology.

[72]  O. Bagasra,et al.  Cellular reservoirs of HIV‐1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry , 1996, AIDS.

[73]  T. Merigan,et al.  Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. , 1996, The New England journal of medicine.

[74]  M. Stoneking,et al.  Nonneutral mitochondrial DNA variation in humans and chimpanzees. , 1996, Genetics.

[75]  G. Kroemer,et al.  Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. , 1995, Blood.

[76]  W. Thomas,et al.  Cellular forms and functions of brain microglia , 1994, Brain Research Bulletin.

[77]  M. Dalakas,et al.  Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[78]  G. D. Pearlson,et al.  Reduced basal ganglia volume in HIV‐1‐associated dementia , 1993, Neurology.

[79]  E. London,et al.  Reduction of cerebral glucose utilization by the HIV envelope glycoprotein Gp-120 , 1991, Experimental Neurology.

[80]  Denham Harman,et al.  The Biologic Clock: The Mitochondria? , 1972, Journal of the American Geriatrics Society.

[81]  D. Harman.  Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.

[82]  Yaakov Stern,et al.  HIV-associated cognitive impairment before and after the advent of combination therapy , 2011, Journal of NeuroVirology.

[83]  Brian Litt,et al.  Behavioral / Systems / Cognitive Hippocampal Gamma Oscillations Increase with Memory Load , 2010 .

[84]  I. Grant,et al.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. , 2008, Archives of neurology.

[85]  P. Jonas,et al.  Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks , 2007, Nature Reviews Neuroscience.

[86]  M. Sawada,et al.  Role of cytokines in inflammatory process in Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.

[87]  Nikos Makris,et al.  Automatically parcellating the human cerebral cortex. , 2004, Cerebral cortex.

[88]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .